|
WO2021029698A1
|
|
Exenatide analogue and use thereof
|
|
KR20210019965A
|
|
Glycosylated exenatide analogs and uses thereof
|
|
CN111100195A
|
|
buforin derivative and application thereof
|
|
KR20200005499A
|
|
Cosmetic composition for eliminating or adsorbing particulate matter comprising peptide complex as effective component
|
|
WO2020013527A1
|
|
Antimicrobial peptide derivative having enhanced antimicrobial activity, hemolytic stability and stability in blood serum
|
|
KR20200006492A
|
|
Antimicrobial peptide derivatives with improved antimicrobial activity, hemolytic stability and serum stability
|
|
KR20190032218A
|
|
Active material-hexapeptide complexes and cosmetic composition comprising same
|
|
KR20190003913A
|
|
Process for the Preparation of Goserelin
|
|
KR20190003912A
|
|
Process for the Preparation of Buserelin
|
|
KR20190001969A
|
|
Process for the Preparation of Triptorelin
|
|
CN108721279A
|
|
Including 5`- hydroxyls -5- nitros-breast cancer treatment agent of the indigo red -3`- oximes as active constituent
|
|
KR101819544B1
|
|
Breast cancer therapeutic agent containing 5'-hydroxy-5-nitro-indirubin-3'-oxime as active ingredient
|
|
KR20160147235A
|
|
Triphenylmethane Derivatives Having Selective Solubility and Their Uses
|
|
KR20160088249A
|
|
Composition for Treating or Preventing Erectile Dysfunction Comprising LDD175 As Active Ingredient
|
|
KR20150111297A
|
|
Novel Exenatide Analogs and Uses thereof
|
|
KR20150114111A
|
|
Process for the Preparation of Desmopressin
|
|
KR20150057047A
|
|
GPCR Ligand Peptides and a Conserved Motif Theirof
|
|
KR20140126802A
|
|
Curcumin-peptide complexes having improved solubility in comparison with curcumin and methods of preparing the same
|
|
KR20140126105A
|
|
Compositions for antioxidation or improvement of skin conditions comprising curcumin-hexapeptide complexes
|
|
KR20140056803A
|
|
Process for the preparation of exenatide
|
